A-Cube
Announcement of Exhibition at BioJapan 2025
Exhibition Information ProteoBridge Inc. will exhi…
HuPEX Index
HuPEX
A HuPEX®-based study published in the international journal OncoImmunology, specializing in cancer immunology
A research article utilizing HuPEX® has been publi…
A-Cube
Notice of Exhibition at JACLaS EXPO 2025
Exhibition Information ProteoBridge Inc. will be e…
A-Cube
Our Technology Featured in Allergy & Rheumatic Diseases September 2025 Issue – Special Feature on “Allergen Immunotherapy”
In the September 2025 issue of Allergy & Rheum…
HuPEX
HuPEX®-Powered Proteomics Research Published in Journal of Proteome Research
Tokyo, Japan – July 25, 2025 – ProteoBridge Inc. (…
A-Cube
The 66th Annual Meeting of the Japanese Society of Neurology has begun! We are introducing HuPEX and many other services at our booth.
At our booth, we will introduce the features of ea…
A-Cube
Exhibiting at the 66th Annual Meeting of the Japanese Society of Neurology
Proteobridge Inc. (Headquarters: Tokyo, President …
HuPEX
A paper using HuPEX ® has been published in the international immunology journal “Immunology Letters”.
This paper focuses on anti-CD320 autoantibodies th…
HuPEX
The Rheumatology Congress has started! We are introducing HuPEX and many other services at our booth.
At our booth, we will introduce the features of ea…
HuPEX
Exhibiting at the 69th General Meeting and Scientific Conference of the Japan College of Rheumatology – Presenting the latest biomarker analysis technology and research results –
Proteobridge Inc. (Headquarters: Tokyo, President …